S

Scandinavian Medical Solutions A/S
CSE:SMSMED

Watchlist Manager
Scandinavian Medical Solutions A/S
CSE:SMSMED
Watchlist
Price: 3.37 DKK -3.44% Market Closed
Market Cap: kr93.7m

Intrinsic Value

The intrinsic value of one SMSMED stock under the Base Case scenario is hidden DKK. Compared to the current market price of 3.37 DKK, Scandinavian Medical Solutions A/S is hidden .

SMSMED Intrinsic Value
HIDDEN
Show

Valuation History
Scandinavian Medical Solutions A/S

Intrinsic Value History
Dive into the past to invest in the future

SMSMED looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if SMSMED is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about SMSMED?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SMSMED valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Scandinavian Medical Solutions A/S.

Explain Valuation
Alternatives to SMSMED

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Scandinavian Medical Solutions A/S

Efficiency

Earnings Waterfall
Scandinavian Medical Solutions A/S

Wall St
Price Targets

Dividends

Scandinavian Medical Solutions A/S
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

What is the Intrinsic Value of one SMSMED stock?

The intrinsic value of one SMSMED stock under the Base Case scenario is hidden DKK.

Is SMSMED stock undervalued or overvalued?

Compared to the current market price of 3.37 DKK, Scandinavian Medical Solutions A/S is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett